Tumor cells are made up of continually dividing cells because of altered telomere activity, causing the rapid and constant proliferation of these cells. Because virions require host cell machinery to replicate, these amplified levels of DNA and protein synthesis in dividing cancer cells make tumor cells better hosts for viral reproduction than non-dividing normal cells.8 Oncolytic viruses are able to hijack the replication machinery of cancer cells as a result of the defective antiviral defenses within tumor cells.5 According to Russell, “Normal cells respond to virus infection by downmodulating their metabolism and/or by undergoing apoptosis, thereby inhibiting virus propagation.”5 Consequently, oncolytic viruses must also combat the body’s innate immune system, as they are vulnerable to antiviral host defenses, such as interferons, killer cells, cytotoxic T cells, and antiviral antibodies.3 Battling the innate immune system is one of the key issues with efficacy of oncolytic